CoChat

Integrin β1 regulates marginal zone B cell differentiation and PI3K signaling

Open access

The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.

Abstract

Marginal zone (MZ) B cells represent innate-like B cells that mediate a fast immune response. The adhesion of MZ B cells to the marginal sinus of the spleen is governed by integrins. Here, we address the question of whether β1-integrin has additional functions by analyzing Itgb1fl/flCD21Cre mice in which the β1-integrin gene is deleted in mature B cells. We find that integrin β1–deficient mice have a defect in the differentiation of MZ B cells and plasma cells. We show that integrin β1–deficient transitional B cells, representing the precursors of MZ B cells, have enhanced B cell receptor (BCR) signaling, altered PI3K and Ras/ERK pathways, and an enhanced interaction of integrin-linked kinase (ILK) with the adaptor protein Grb2. Moreover, the MZ B cell defect of integrin β1–deficient mice could, at least in part, be restored by a pharmacological inhibition of the PI3K pathway. Thus, β1-integrin has an unexpected function in the differentiation and function of MZ B cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20220342

Cites

95 of 95 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. MZ B cell frequencies are reduced in β1KO mice. (A) Flow cytometry to identify Fo (CD23hiCD21low) and MZ B cells (CD23lowCD21hi) in spleen from Itgb1+/+Cd19cre and Itgb1fl/flCd19cre mice. Numbers represent cell frequencies. (B) Mean (±SD) frequencies of Fo and MZ B cells in spleen from Itgb1+/+Cd19cre and Itgb1fl/flCd19cre mice, as gated in A. (C) Flow cytometry to identify Fo (CD23hiCD21low) and MZ B cells (CD23lowCD21hi) in spleen from Itgb1+/+Cd21cre (β1WT) and Itgb1fl/flCd21cre (β1KO) mice. ( and E) Numbers represent cell frequencies. Mean (±SD) frequencies (D) and absolute numbers (E) of Fo and MZ B cells in spleen from β1WT and β1KO mice, as gated in C. (F) Mean (±SD) absolute numbers and frequencies of transitional B cells (T1-T3) from β1WT and β1KO mice. (A–F) n = 5–9 mice. Each circle in the graphs represents data from one mouse. Data are representative of five different experiments. Mean and SD are indicated by horizontal lines in the data points; significance is calculated by unpaired Student’s t test (****P < 0.0001). (G) Immunofluorescence staining for MOMA to define the MZ (blue) and IgM (red) for B cells in the spleens of β1WT and β1KO mice. n = 3 mice. Scale bars, 100 µm.
Figure 1. MZ B cell frequencies are reduced in β1KO mice. (A) Flow cytometry to identify Fo (CD23hiCD21low) and MZ B cells (CD23lowCD21hi) in spleen from Itgb1+/+Cd19cre and Itgb1fl/flCd19cre mice. Numbers represent cell frequencies. (B) Mean (±SD) frequencies of Fo and MZ B cells in spleen from Itgb1+/+Cd19cre and Itgb1fl/flCd19cre mice, as gated in A. (C) Flow cytometry to identify Fo (CD23hiCD21low) and MZ B cells (CD23lowCD21hi) in spleen from Itgb1+/+Cd21cre (β1WT) and Itgb1fl/flCd21cre (β1KO) mice. ( and E) Numbers represent cell frequencies. Mean (±SD) frequencies (D) and absolute numbers (E) of Fo and MZ B cells in spleen from β1WT and β1KO mice, as gated in C. (F) Mean (±SD) absolute numbers and frequencies of transitional B cells (T1-T3) from β1WT and β1KO mice. (A–F) n = 5–9 mice. Each circle in the graphs represents data from one mouse. Data are representative of five different experiments. Mean and SD are indicated by horizontal lines in the data points; significance is calculated by unpaired Student’s t test (****P < 0.0001). (G) Immunofluorescence staining for MOMA to define the MZ (blue) and IgM (red) for B cells in the spleens of β1WT and β1KO mice. n = 3 mice. Scale bars, 100 µm.CC BY · PubMed Central
Figure S1. Reduced β1-integrin expression and reduced MZ B cell numbers in β1KO mice. Related to Fig. 1. (A) Histograms analysis (upper panels) and MFI quantification (lower panels) of β1-, α4-, αL-, and β2-integrins in Fo (orange) and MZ (blue) B cells from β1WT and β1KO mice. (B) Flow cytometry to identify Fo (CD23hiCD1dlow) and MZ B cells (CD23lowCD1dhi) in spleen from β1WT and β1KO mice. (C) Mean (±SD) frequencies and absolute numbers of Fo and MZ B cells in spleen from β1WT and β1KO mice, as gated in B. (A–C) n = 3–5 mice. Each circle in the graphs represents data from one animal. Data are representative of four independent experiments. Mean and SD are indicated by horizontal lines in the data points; significance is calculated by unpaired Student’s t test (**P < 0.01, ***P < 0.001, ****P < 0.0001). (D) Immunofluorescence staining for MOMA to define the MZ (blue), IgD (green) for B cells and CD1d (red) for MZ B cells, in the spleens of β1WT and β1KO mice. n = 3 mice. Scale bars, 100 µm.
Figure S1. Reduced β1-integrin expression and reduced MZ B cell numbers in β1KO mice. Related to Fig. 1. (A) Histograms analysis (upper panels) and MFI quantification (lower panels) of β1-, α4-, αL-, and β2-integrins in Fo (orange) and MZ (blue) B cells from β1WT and β1KO mice. (B) Flow cytometry to identify Fo (CD23hiCD1dlow) and MZ B cells (CD23lowCD1dhi) in spleen from β1WT and β1KO mice. (C) Mean (±SD) frequencies and absolute numbers of Fo and MZ B cells in spleen from β1WT and β1KO mice, as gated in B. (A–C) n = 3–5 mice. Each circle in the graphs represents data from one animal. Data are representative of four independent experiments. Mean and SD are indicated by horizontal lines in the data points; significance is calculated by unpaired Student’s t test (**P < 0.01, ***P < 0.001, ****P < 0.0001). (D) Immunofluorescence staining for MOMA to define the MZ (blue), IgD (green) for B cells and CD1d (red) for MZ B cells, in the spleens of β1WT and β1KO mice. n = 3 mice. Scale bars, 100 µm.CC BY · PubMed Central
Figure S2. β1KO mice have normal PC differentiation in TD immune responses. Related to Fig. 2. (A) Flow cytometry analysis of β1WT and β1KO peripheral blood cells showing the Fo (CD23hiCD21low) and MZ (CD23lowCD21hi) B cell populations. (B) Mean (±SD) frequencies of Fo and MZ B cells in peripheral blood of β1WT and β1KO mice, as gated in A. (C) Mean (±SD) frequencies of transitional (T1–T3), Fo, and MZ B Annexin V+ cells in spleens of β1WT and β1KO mice. (D) Mean (±SD) frequencies within each cell cycle phase of transitional (T1–T3), Fo, and MZ B from spleens of β1WT and β1KO mice. (A–D) n = 3–13 mice. Each circle in the graphs represents data from one animal. (E) Flow cytometry to identify CD138+Blimp-GFP+ cells among B220+ β1WTPrdm1+/gfp and β1KOPrdm1+/gfp splenocytes that were stimulated with CD40L, IL4, and IL5 in vitro for 5 d. Numbers represent cell frequencies. (F) Mean (±SD) frequencies and numbers of CD138+Blimp-GFP+ cells, as gated in E. (G) Flow cytometry to detect CD138+Blimp-GFP+ cells in the BM of β1WTPrdm1+/gfp and β1KO Prdm1+/gfp mice 7 d p.i. with NP-KLH. Numbers represent cell frequencies. (H) Mean (±SD) frequencies of β1WT and β1KO CD138+Blimp-GFPint and CD138+Blimp-GFPhi cells in BM, as gated in G. (I and J) Flow cytometry to determine the frequencies of GC B cells in β1WT and β1KO mice 7 d p.i. with NP-KLH. Representative dot plots (I) and mean (±SD) frequencies and numbers (J) of GL7+ Fas+ GC B cells in spleens of NP-KLH immunized mice. n = 3–5 mice. Each circle in the graphs represents data from one animal. Mean and SD are indicated by horizontal lines in the data points. Data are representative of three independent experiments.
Figure S2. β1KO mice have normal PC differentiation in TD immune responses. Related to Fig. 2. (A) Flow cytometry analysis of β1WT and β1KO peripheral blood cells showing the Fo (CD23hiCD21low) and MZ (CD23lowCD21hi) B cell populations. (B) Mean (±SD) frequencies of Fo and MZ B cells in peripheral blood of β1WT and β1KO mice, as gated in A. (C) Mean (±SD) frequencies of transitional (T1–T3), Fo, and MZ B Annexin V+ cells in spleens of β1WT and β1KO mice. (D) Mean (±SD) frequencies within each cell cycle phase of transitional (T1–T3), Fo, and MZ B from spleens of β1WT and β1KO mice. (A–D) n = 3–13 mice. Each circle in the graphs represents data from one animal. (E) Flow cytometry to identify CD138+Blimp-GFP+ cells among B220+ β1WTPrdm1+/gfp and β1KOPrdm1+/gfp splenocytes that were stimulated with CD40L, IL4, and IL5 in vitro for 5 d. Numbers represent cell frequencies. (F) Mean (±SD) frequencies and numbers of CD138+Blimp-GFP+ cells, as gated in E. (G) Flow cytometry to detect CD138+Blimp-GFP+ cells in the BM of β1WTPrdm1+/gfp and β1KO Prdm1+/gfp mice 7 d p.i. with NP-KLH. Numbers represent cell frequencies. (H) Mean (±SD) frequencies of β1WT and β1KO CD138+Blimp-GFPint and CD138+Blimp-GFPhi cells in BM, as gated in G. (I and J) Flow cytometry to determine the frequencies of GC B cells in β1WT and β1KO mice 7 d p.i. with NP-KLH. Representative dot plots (I) and mean (±SD) frequencies and numbers (J) of GL7+ Fas+ GC B cells in spleens of NP-KLH immunized mice. n = 3–5 mice. Each circle in the graphs represents data from one animal. Mean and SD are indicated by horizontal lines in the data points. Data are representative of three independent experiments.CC BY · PubMed Central
Figure 2. β1-integrin regulates TI PC differentiation. (A) IgM (left panel) and IgG3 (right panel) serum levels in β1WT and β1KO mice at different time points p.i. with TNP-LPS. (B) IgM (left panel) and IgG1 (right panel) serum levels in β1WT and β1KO mice at different time points p.i. with NP-KLH. (A and B) n = 5 mice. Data are from three independent experiments. (C) Flow cytometry to identify CD138−Blimp-GFP− Act B cells, CD138−Blimp-GFP+ pre-PBs, and CD138+Blimp-GFP+ PBs 4 d after LPS stimulation of β1WTPrdm1+/gfp and β1KOPrdm1+/gfp B220+ splenocytes. Numbers represent cell frequencies. (D) Mean (±SD) frequencies and absolute numbers of the populations gated in C. (E) Flow cytometry to detect CD138+Blimp-GFP+ cells in the spleen (upper) and BM (lower) of β1WTPrdm1+/gfp and β1KOPrdm1+/gfp mice 3 d p.i. with TNP-LPS. Numbers represent cell frequencies. (F) Mean (±SD) frequencies of β1WT and β1KO CD138+Blimp-GFPint and CD138+Blimp-GFPhi cells in the spleen and BM, as gated in E. (G) Flow cytometry to identify CD138+Blimp-GFP+ cells in spleen cells from β1WTPrdm1+/gfp and β1KOPrdm1+/gfp mice 7 d p.i. with NP-KLH. Numbers represent cell frequencies. (H) Mean (±SD) frequencies of CD138+Blimp-GFPint and CD138+Blimp-GFPhi cells in spleens from β1WTPrdm1+/gfp and β1KOPrdm1+/gfp mice, as gated in G. (C–H) n = 4–7 mice. Each circle in the graphs represents data from one animal. Data are representative of three independent experiments. Mean and SD are indicated by horizontal lines in the data points; significance is calculated by one-way ANOVA test (*P < 0.05, **P < 0.01, ***P < 0.001).
Figure 2. β1-integrin regulates TI PC differentiation. (A) IgM (left panel) and IgG3 (right panel) serum levels in β1WT and β1KO mice at different time points p.i. with TNP-LPS. (B) IgM (left panel) and IgG1 (right panel) serum levels in β1WT and β1KO mice at different time points p.i. with NP-KLH. (A and B) n = 5 mice. Data are from three independent experiments. (C) Flow cytometry to identify CD138−Blimp-GFP− Act B cells, CD138−Blimp-GFP+ pre-PBs, and CD138+Blimp-GFP+ PBs 4 d after LPS stimulation of β1WTPrdm1+/gfp and β1KOPrdm1+/gfp B220+ splenocytes. Numbers represent cell frequencies. (D) Mean (±SD) frequencies and absolute numbers of the populations gated in C. (E) Flow cytometry to detect CD138+Blimp-GFP+ cells in the spleen (upper) and BM (lower) of β1WTPrdm1+/gfp and β1KOPrdm1+/gfp mice 3 d p.i. with TNP-LPS. Numbers represent cell frequencies. (F) Mean (±SD) frequencies of β1WT and β1KO CD138+Blimp-GFPint and CD138+Blimp-GFPhi cells in the spleen and BM, as gated in E. (G) Flow cytometry to identify CD138+Blimp-GFP+ cells in spleen cells from β1WTPrdm1+/gfp and β1KOPrdm1+/gfp mice 7 d p.i. with NP-KLH. Numbers represent cell frequencies. (H) Mean (±SD) frequencies of CD138+Blimp-GFPint and CD138+Blimp-GFPhi cells in spleens from β1WTPrdm1+/gfp and β1KOPrdm1+/gfp mice, as gated in G. (C–H) n = 4–7 mice. Each circle in the graphs represents data from one animal. Data are representative of three independent experiments. Mean and SD are indicated by horizontal lines in the data points; significance is calculated by one-way ANOVA test (*P < 0.05, **P < 0.01, ***P < 0.001).CC BY · PubMed Central
Figure 3. β1-integrin affects the transcriptional program of MZ B cell differentiation. (A) Scatter plot of gene-expression levels in β1WT (x axis) and β1KO (y axis) Fo B (left), transitional B (center), and MZ B (right) cells. The unaltered (gray), up- (red), and downregulated (green) genes are highlighted. (B) Expression levels (fragments per kilobase of transcript per million mapped reads [FPKM]) of differentially expressed key genes in β1WT and β1KO Fo B, transitional B, and MZ B cells. Error bars indicate SD; n = 3. (C) The top 10 enriched hallmark gene sets (y axis) in the differentially expressed genes of β1KO MZ B cells relative to β1WT MZ B cells. Gene sets are ordered by normalized enrichment score (x axis). (D) List and overlap of enriched genes (from C) in the hallmark gene sets G2M checkpoint, E2F targets, Myc targets, and IL2-STAT5 pathway. RNA-seq was performed once.
Figure 3. β1-integrin affects the transcriptional program of MZ B cell differentiation. (A) Scatter plot of gene-expression levels in β1WT (x axis) and β1KO (y axis) Fo B (left), transitional B (center), and MZ B (right) cells. The unaltered (gray), up- (red), and downregulated (green) genes are highlighted. (B) Expression levels (fragments per kilobase of transcript per million mapped reads [FPKM]) of differentially expressed key genes in β1WT and β1KO Fo B, transitional B, and MZ B cells. Error bars indicate SD; n = 3. (C) The top 10 enriched hallmark gene sets (y axis) in the differentially expressed genes of β1KO MZ B cells relative to β1WT MZ B cells. Gene sets are ordered by normalized enrichment score (x axis). (D) List and overlap of enriched genes (from C) in the hallmark gene sets G2M checkpoint, E2F targets, Myc targets, and IL2-STAT5 pathway. RNA-seq was performed once.CC BY · PubMed Central
Figure 4. β1-integrin regulates BCR signaling in transitional B cells. (A) MZ B cells from β1WT and β1KO mice were stimulated for different time points with anti-mouse IgM F(ab′)2 antibody and the phosphorylation of Syk (left) and Lyn (right) was evaluated by flow cytometry. Mean (±SD) of mean fluorescence intensity (MFI) is plotted. (B and C) Ca2+ influx was measured in β1WT and β1KO MZ (B) and transitional (C) B cells. Cells were stained with Indo-1 and the ratio of Ca2+-bound Indo-1 to Ca2+-unbound Indo-1 was measured by flow cytometry. Stimulation was induced after 60 s of the measurement with anti-IgM (5 µg/ml; arrow). Data are representative of three independent experiments. (D) β1WT and β1KO transitional B cells were stimulated for different time points with anti-mouse IgM F(ab′)2 antibody and the phosphorylation of Syk and Lyn was evaluated by Western blot. (E) A quantification of the phospho-Syk (left) and phospho-Lyn (right)/loading control ratio after normalization is shown for independently performed experiments as in D. The mean ± SD is plotted. (F) β1WT and β1KO transitional B cells were stimulated for different time points with anti-mouse IgM F(ab′)2 antibody and the phosphorylation of Akt and Erk was evaluated by Western blot. (G) A quantification of the phospho-Akt (left) and phospho-Erk (right)/loading control ratio after normalization is shown for independently performed experiments as in F. The mean ± SD is plotted. (A–G) n = 3–5 mice. Data are representative of three independent experiments. Significance was calculated by one-way ANOVA test (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001). Source data are available for this figure: SourceData F4.
Figure 4. β1-integrin regulates BCR signaling in transitional B cells. (A) MZ B cells from β1WT and β1KO mice were stimulated for different time points with anti-mouse IgM F(ab′)2 antibody and the phosphorylation of Syk (left) and Lyn (right) was evaluated by flow cytometry. Mean (±SD) of mean fluorescence intensity (MFI) is plotted. (B and C) Ca2+ influx was measured in β1WT and β1KO MZ (B) and transitional (C) B cells. Cells were stained with Indo-1 and the ratio of Ca2+-bound Indo-1 to Ca2+-unbound Indo-1 was measured by flow cytometry. Stimulation was induced after 60 s of the measurement with anti-IgM (5 µg/ml; arrow). Data are representative of three independent experiments. (D) β1WT and β1KO transitional B cells were stimulated for different time points with anti-mouse IgM F(ab′)2 antibody and the phosphorylation of Syk and Lyn was evaluated by Western blot. (E) A quantification of the phospho-Syk (left) and phospho-Lyn (right)/loading control ratio after normalization is shown for independently performed experiments as in D. The mean ± SD is plotted. (F) β1WT and β1KO transitional B cells were stimulated for different time points with anti-mouse IgM F(ab′)2 antibody and the phosphorylation of Akt and Erk was evaluated by Western blot. (G) A quantification of the phospho-Akt (left) and phospho-Erk (right)/loading control ratio after normalization is shown for independently performed experiments as in F. The mean ± SD is plotted. (A–G) n = 3–5 mice. Data are representative of three independent experiments. Significance was calculated by one-way ANOVA test (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001). Source data are available for this figure: SourceData F4.CC BY · PubMed Central
Figure S3. β1KO MZ B cells have altered self-antigen recognition. Related to Fig. 4. (A) Fo B cells from β1WT and β1KO mice were stimulated for different time points with anti-mouse IgM F(ab′)2 antibody and the phosphorylation of Syk (left) and Lyn (right) was evaluated by flow cytometry. Mean (±SD) of MFI is plotted. (B) Ca2+ influx was measured in β1WT and β1KO Fo B cells. Cells were stained with Indo-1 and the ratio of Ca2+-bound Indo-1 to Ca2+-unbound Indo-1 was measured by flow cytometry. Stimulation was induced after 60 s of the measurement with anti-IgM (5 µg/ml; arrow). (C and D) Flow cytometry (C) and mean (±SD) frequencies (D) of NP+ Igλ+ and NP+ Igλlow cells in the spleen of β1WTIghB1-8 and β1KOIghB1-8 mice. (E and F) Flow cytometry (E) and mean (±SD) frequencies (F) of non-MZ (CD23hiCD21low) and MZ B (CD23lowCD21hi) cells gated in the NP+ Igλlow population of β1WTIghB1-8 and β1KOIghB1-8 mice. (A–F) n = 3–5 mice. Each circle in the graphs represents data from one animal. Data are representative of three different experiments. Mean and SD are indicated by horizontal lines in the data points; significance is calculated by unpaired Student’s t test (*P < 0.05).
Figure S3. β1KO MZ B cells have altered self-antigen recognition. Related to Fig. 4. (A) Fo B cells from β1WT and β1KO mice were stimulated for different time points with anti-mouse IgM F(ab′)2 antibody and the phosphorylation of Syk (left) and Lyn (right) was evaluated by flow cytometry. Mean (±SD) of MFI is plotted. (B) Ca2+ influx was measured in β1WT and β1KO Fo B cells. Cells were stained with Indo-1 and the ratio of Ca2+-bound Indo-1 to Ca2+-unbound Indo-1 was measured by flow cytometry. Stimulation was induced after 60 s of the measurement with anti-IgM (5 µg/ml; arrow). (C and D) Flow cytometry (C) and mean (±SD) frequencies (D) of NP+ Igλ+ and NP+ Igλlow cells in the spleen of β1WTIghB1-8 and β1KOIghB1-8 mice. (E and F) Flow cytometry (E) and mean (±SD) frequencies (F) of non-MZ (CD23hiCD21low) and MZ B (CD23lowCD21hi) cells gated in the NP+ Igλlow population of β1WTIghB1-8 and β1KOIghB1-8 mice. (A–F) n = 3–5 mice. Each circle in the graphs represents data from one animal. Data are representative of three different experiments. Mean and SD are indicated by horizontal lines in the data points; significance is calculated by unpaired Student’s t test (*P < 0.05).CC BY · PubMed Central
Figure 5. β1-integrin regulates MZ B cell differentiation. (A and B) Flow cytometry to identify the induction of CD1d and CD21 (A) and IgM and CD21 (B) expression on transitional B cells from β1WT and β1KO mice, cultured on OP9 or OP9-Dll1 cells for 3 d. (C and D) Mean (±SD) frequencies and absolute numbers of the increase in CD1dhi CD21hi (C) and IgM+CD21hi cells (D), as gated in A and B. (A–D) n = 3. Each circle in the graphs represents data from one animal. Data are representative of three independent experiments. Mean and SD are indicated by horizontal lines in the data points; significance is calculated by one-way ANOVA test (**P < 0.01, ****P < 0.0001). (E) The Venn diagram represents the overlap of in vitro OP9-Dll1 culture and primary MZ B cell datasets of the differentially expressed genes between β1KO and β1WT cells. The up- and downregulated genes are grouped separately for each comparison. A 1.5-fold change was used as a cutoff for primary cells and a twofold change for in vitro data. (F) The overlap of differentially expressed genes in the comparison of β1KO and β1WT MZ B cell with the upregulated genes in β1KO cells relative to β1WT cells cultured in the presence of OP9-Dll1 cells. The differentially expressed genes in MZ B cells are ranked (y axis) according to the fold-change (x axis). The genes upregulated in the in vitro OP9-Dll1 culture are indicated (right, red). The key genes of interest are highlighted in the figure. RNA-seq was performed once.
Figure 5. β1-integrin regulates MZ B cell differentiation. (A and B) Flow cytometry to identify the induction of CD1d and CD21 (A) and IgM and CD21 (B) expression on transitional B cells from β1WT and β1KO mice, cultured on OP9 or OP9-Dll1 cells for 3 d. (C and D) Mean (±SD) frequencies and absolute numbers of the increase in CD1dhi CD21hi (C) and IgM+CD21hi cells (D), as gated in A and B. (A–D) n = 3. Each circle in the graphs represents data from one animal. Data are representative of three independent experiments. Mean and SD are indicated by horizontal lines in the data points; significance is calculated by one-way ANOVA test (**P < 0.01, ****P < 0.0001). (E) The Venn diagram represents the overlap of in vitro OP9-Dll1 culture and primary MZ B cell datasets of the differentially expressed genes between β1KO and β1WT cells. The up- and downregulated genes are grouped separately for each comparison. A 1.5-fold change was used as a cutoff for primary cells and a twofold change for in vitro data. (F) The overlap of differentially expressed genes in the comparison of β1KO and β1WT MZ B cell with the upregulated genes in β1KO cells relative to β1WT cells cultured in the presence of OP9-Dll1 cells. The differentially expressed genes in MZ B cells are ranked (y axis) according to the fold-change (x axis). The genes upregulated in the in vitro OP9-Dll1 culture are indicated (right, red). The key genes of interest are highlighted in the figure. RNA-seq was performed once.CC BY · PubMed Central
Figure S4. β1KO transitional B cells show normal survival and Notch2 expression but different transcriptional profile during differentiation. Related to Fig. 5. (A) Western blot to show Notch2 expression in transitional B cells from β1WT and β1KO mice. H3 expression was used as a loading control. Each line represents a different mouse. (B) Fold-change in survival of β1WT and β1KO transitional B cells, cultured in OP9-Dll1 for 72 h in the absence or presence of the survival factor BAFF. (C) Mean (±SD) frequencies of IgM+CD21hi cells cultured in OP9 (left panel) and in OP9-Dll1 (right panel) cells for 3 d, with different indicated concentrations of γ-secretase inhibitor or with DMSO (vehicle control). (A–C) n = 3 mice. Data are representative of at least three experiments; significance calculated by unpaired Student’s t test (*P < 0.05, **P < 0.01, *** P < 0.001, ****P < 0.0001). (D) Scatter plots represent gene-expression levels of β1WT (x axis) and β1KO (y axis) transitional B cells cultured in OP9 (left) and OP9-Dll1 (right). The unaltered (gray), up- (red), and downregulated (green) genes are highlighted. (E) Functional classification of up- (red) and downregulated (green) genes in β1KO transitional B cells cultured in OP9-Dll1 relative to OP9 stromal cells. Numbers next to the bars indicate number of genes associated with each functional class. (F) The Venn diagram (left) represents the overlap of in vitro OP9-Dll1 culture and primary transitional B cell datasets of the differentially expressed genes between β1KO and β1WT cells. The up- and downregulated genes are grouped separately for each comparison. A 1.5-fold change was used as a cutoff for primary cells and a twofold change for in vitro data. List of the 48 upregulated genes (right) represented in the Venn diagram. Those genes that also overlap between the in vitro OP9-Dll1 culture and primary MZ B cell datasets are highlighted in blue. (G) Expression levels (FPKM) of differentially expressed key genes in β1WT and β1KO transitional B cells cultured in OP9 and OP9-Dll1 cells. Error bars indicate SD; n = 2. RNA-seq was performed once. Source data are available for this figure: SourceData FS4.
Figure S4. β1KO transitional B cells show normal survival and Notch2 expression but different transcriptional profile during differentiation. Related to Fig. 5. (A) Western blot to show Notch2 expression in transitional B cells from β1WT and β1KO mice. H3 expression was used as a loading control. Each line represents a different mouse. (B) Fold-change in survival of β1WT and β1KO transitional B cells, cultured in OP9-Dll1 for 72 h in the absence or presence of the survival factor BAFF. (C) Mean (±SD) frequencies of IgM+CD21hi cells cultured in OP9 (left panel) and in OP9-Dll1 (right panel) cells for 3 d, with different indicated concentrations of γ-secretase inhibitor or with DMSO (vehicle control). (A–C) n = 3 mice. Data are representative of at least three experiments; significance calculated by unpaired Student’s t test (*P < 0.05, **P < 0.01, *** P < 0.001, ****P < 0.0001). (D) Scatter plots represent gene-expression levels of β1WT (x axis) and β1KO (y axis) transitional B cells cultured in OP9 (left) and OP9-Dll1 (right). The unaltered (gray), up- (red), and downregulated (green) genes are highlighted. (E) Functional classification of up- (red) and downregulated (green) genes in β1KO transitional B cells cultured in OP9-Dll1 relative to OP9 stromal cells. Numbers next to the bars indicate number of genes associated with each functional class. (F) The Venn diagram (left) represents the overlap of in vitro OP9-Dll1 culture and primary transitional B cell datasets of the differentially expressed genes between β1KO and β1WT cells. The up- and downregulated genes are grouped separately for each comparison. A 1.5-fold change was used as a cutoff for primary cells and a twofold change for in vitro data. List of the 48 upregulated genes (right) represented in the Venn diagram. Those genes that also overlap between the in vitro OP9-Dll1 culture and primary MZ B cell datasets are highlighted in blue. (G) Expression levels (FPKM) of differentially expressed key genes in β1WT and β1KO transitional B cells cultured in OP9 and OP9-Dll1 cells. Error bars indicate SD; n = 2. RNA-seq was performed once. Source data are available for this figure: SourceData FS4.CC BY · PubMed Central
Figure 6. β1-integrin effect is cell intrinsic. (A) Flow cytometry to identify the induction of CD21 and IgM expression on transitional B cells from β1WT mice that were incubated for 30 min with different concentrations of a blocking anti–β1-integrin antibody or with the corresponding IgG control antibody, and later cultured on OP9 or OP9-Dll1 cells for 3 d. (B) Mean (±SD) frequencies of the increase in IgM+CD21hi cells, as gated in A. (C and D) Quantification (MFI; C) and representative histograms (D) of VCAM-1 expression in OP9 and OP9-Dll1 stromal cells, Fo, transitional, and MZ B cells. BM macrophages were used as positive control. IC, isotype control. (A–D) n = 3. Each circle in the graphs represents data from one mouse. Data are representative of three independent experiments. Mean and SD are indicated by horizontal lines in the data points; significance is calculated by one-way ANOVA test (**P < 0.01, ****P < 0.0001).
Figure 6. β1-integrin effect is cell intrinsic. (A) Flow cytometry to identify the induction of CD21 and IgM expression on transitional B cells from β1WT mice that were incubated for 30 min with different concentrations of a blocking anti–β1-integrin antibody or with the corresponding IgG control antibody, and later cultured on OP9 or OP9-Dll1 cells for 3 d. (B) Mean (±SD) frequencies of the increase in IgM+CD21hi cells, as gated in A. (C and D) Quantification (MFI; C) and representative histograms (D) of VCAM-1 expression in OP9 and OP9-Dll1 stromal cells, Fo, transitional, and MZ B cells. BM macrophages were used as positive control. IC, isotype control. (A–D) n = 3. Each circle in the graphs represents data from one mouse. Data are representative of three independent experiments. Mean and SD are indicated by horizontal lines in the data points; significance is calculated by one-way ANOVA test (**P < 0.01, ****P < 0.0001).CC BY · PubMed Central
Figure S5. Increased p-CD19 levels in β1KO transitional and MZ B cells and list of deregulated genes in transitional B cells treated with PI3K inhibitor. Related to Figs. 7 and 8. (A) Transitional and MZ B cells from β1WT and β1KO mice were stimulated for different time points with anti-mouse IgM F(ab′)2 antibody and the phosphorylation of CD19 was evaluated by flow cytometry. (B) Mean (±SD) of phosphorylation of CD19 MFI is plotted. (A and B) n = 3 mice. Data are representative of three different experiments; significance is calculated by ANOVA test (* P < 0.05, *** P < 0.001). (C and D) Selected list of key genes from functional classification of up- (red) and downregulated (green) genes in PI3K inhibitor–treated β1WT (C) and β1KO (D) transitional B cells. RNA-seq was performed once. (E) Lysates of transitional β1WT and β1KO B cells were incubated with beads cross-linked with α-Grb2 or control α-Ig antibodies. Samples were washed and resolved by SDS-PAGE. Grb2 and FAK were detected by immunoblot analysis with specific antibodies. Data are representative of two independent experiments. Source data are available for this figure: SourceData FS5.
Figure S5. Increased p-CD19 levels in β1KO transitional and MZ B cells and list of deregulated genes in transitional B cells treated with PI3K inhibitor. Related to Figs. 7 and 8. (A) Transitional and MZ B cells from β1WT and β1KO mice were stimulated for different time points with anti-mouse IgM F(ab′)2 antibody and the phosphorylation of CD19 was evaluated by flow cytometry. (B) Mean (±SD) of phosphorylation of CD19 MFI is plotted. (A and B) n = 3 mice. Data are representative of three different experiments; significance is calculated by ANOVA test (* P < 0.05, *** P < 0.001). (C and D) Selected list of key genes from functional classification of up- (red) and downregulated (green) genes in PI3K inhibitor–treated β1WT (C) and β1KO (D) transitional B cells. RNA-seq was performed once. (E) Lysates of transitional β1WT and β1KO B cells were incubated with beads cross-linked with α-Grb2 or control α-Ig antibodies. Samples were washed and resolved by SDS-PAGE. Grb2 and FAK were detected by immunoblot analysis with specific antibodies. Data are representative of two independent experiments. Source data are available for this figure: SourceData FS5.CC BY · PubMed Central
Figure 7. PI3K pathway inhibition partially rescues the β1KO MZ B cell phenotype. (A and B) Flow cytometry to identify the induction of CD1d and CD21 (A) and IgM and CD21 (B) expression on transitional B cells from β1WT and β1KO mice, cultured on OP9 or OP9-Dll1 cells for 3 d in the absence (DMSO) or presence of the PI3K inhibitor (PI3K-inh.). (C and D) Mean (±SD) frequencies (upper panel) and absolute numbers (lower panel) of the increase in CD1dhi CD21hi (C) and IgM+CD21hi cells (D), as gated in A and B. (A–D) n = 3 mice. Each circle in the graphs represents data from one mouse. Data are representative of three independent experiments. Mean and SD are indicated by horizontal lines in the data points; significance is calculated by one-way ANOVA test (*P < 0.05, **P < 0.01, ***P < 0.001). (E) Scatter plots depict the gene-expression levels in DMSO-treated (x axis) and PI3K inhibitor–treated (y axis) β1WT (left panel) and β1KO (right panel) transitional B cells, cultured in OP9-Dll1 cells, as described in A and B. The unaltered (gray), up- (red), and downregulated (green) genes are highlighted. (F) The Venn diagram represents the overlap of the differentially expressed genes in the primary MZ B cells with the differentially expressed genes in OP9-Dll1 culture of WT cells treated with PI3K-inh. or DMSO. The up- and downregulated genes are grouped separately for each comparison. A 1.5-fold change was used as a cutoff for primary cells and a twofold change for in vitro data. (G) The overlap of differentially expressed genes in the comparison of β1KO and β1WT MZ B cells with the upregulated genes in the comparison of OP9-Dll1 culture of WT cells treated with PI3K inhibitor or DMSO. The differentially expressed genes in MZ B cells are ranked (y axis) according to the fold-change (x axis). The genes upregulated after treatment with PI3K inhibitor are indicated (right, red). The key genes of interest are highlighted in the figure. (H) Expression levels (FPKM) of differentially expressed key genes in DMSO or PI3K-inh.–treated transitional β1WT and β1KO B cells, cultured in the presence of OP9-Dll1 cells, as described in A and B. Error bars indicates SD; n = 2.
Figure 7. PI3K pathway inhibition partially rescues the β1KO MZ B cell phenotype. (A and B) Flow cytometry to identify the induction of CD1d and CD21 (A) and IgM and CD21 (B) expression on transitional B cells from β1WT and β1KO mice, cultured on OP9 or OP9-Dll1 cells for 3 d in the absence (DMSO) or presence of the PI3K inhibitor (PI3K-inh.). (C and D) Mean (±SD) frequencies (upper panel) and absolute numbers (lower panel) of the increase in CD1dhi CD21hi (C) and IgM+CD21hi cells (D), as gated in A and B. (A–D) n = 3 mice. Each circle in the graphs represents data from one mouse. Data are representative of three independent experiments. Mean and SD are indicated by horizontal lines in the data points; significance is calculated by one-way ANOVA test (*P < 0.05, **P < 0.01, ***P < 0.001). (E) Scatter plots depict the gene-expression levels in DMSO-treated (x axis) and PI3K inhibitor–treated (y axis) β1WT (left panel) and β1KO (right panel) transitional B cells, cultured in OP9-Dll1 cells, as described in A and B. The unaltered (gray), up- (red), and downregulated (green) genes are highlighted. (F) The Venn diagram represents the overlap of the differentially expressed genes in the primary MZ B cells with the differentially expressed genes in OP9-Dll1 culture of WT cells treated with PI3K-inh. or DMSO. The up- and downregulated genes are grouped separately for each comparison. A 1.5-fold change was used as a cutoff for primary cells and a twofold change for in vitro data. (G) The overlap of differentially expressed genes in the comparison of β1KO and β1WT MZ B cells with the upregulated genes in the comparison of OP9-Dll1 culture of WT cells treated with PI3K inhibitor or DMSO. The differentially expressed genes in MZ B cells are ranked (y axis) according to the fold-change (x axis). The genes upregulated after treatment with PI3K inhibitor are indicated (right, red). The key genes of interest are highlighted in the figure. (H) Expression levels (FPKM) of differentially expressed key genes in DMSO or PI3K-inh.–treated transitional β1WT and β1KO B cells, cultured in the presence of OP9-Dll1 cells, as described in A and B. Error bars indicates SD; n = 2.CC BY · PubMed Central
Figure 8. Grb2 adaptor interacts with ILK in β1KO transitional B cells. (A) Analysis of the expression by Western blot of ILK and Grb2 in β1WT and β1KO transitional B cells. Tubulin expression was used as a loading control. Each line represents a different mouse. A quantification of ILK (left) and Grb2 (right)/loading control ratio after normalization is shown for independently performed experiments. The mean ± SD is plotted. Co-IP to detect the association of Grb2 with ILK. (B and C) Lysates of β1WT and β1KO Fo (B) and transitional (C) B cells were incubated with beads cross-linked with α-ILK or control α-Ig antibodies. Samples were washed and resolved by SDS/PAGE. Grb2 and ILK were detected by immunoblot analysis with specific antibodies. A quantification of the Grb2/ILK ratio for transitional B cells is shown for independently performed experiments. Co-IPs with α-ILK and control α-Ig antibodies are represented by black and red dots, respectively. The mean ± SD is plotted. (A–C) n = 3 mice. Each circle in the graphs represents data from one mouse. Data are representative of three independent experiments. Mean and SD are indicated by horizontal lines in the data points. Source data are available for this figure: SourceData F8.
Figure 8. Grb2 adaptor interacts with ILK in β1KO transitional B cells. (A) Analysis of the expression by Western blot of ILK and Grb2 in β1WT and β1KO transitional B cells. Tubulin expression was used as a loading control. Each line represents a different mouse. A quantification of ILK (left) and Grb2 (right)/loading control ratio after normalization is shown for independently performed experiments. The mean ± SD is plotted. Co-IP to detect the association of Grb2 with ILK. (B and C) Lysates of β1WT and β1KO Fo (B) and transitional (C) B cells were incubated with beads cross-linked with α-ILK or control α-Ig antibodies. Samples were washed and resolved by SDS/PAGE. Grb2 and ILK were detected by immunoblot analysis with specific antibodies. A quantification of the Grb2/ILK ratio for transitional B cells is shown for independently performed experiments. Co-IPs with α-ILK and control α-Ig antibodies are represented by black and red dots, respectively. The mean ± SD is plotted. (A–C) n = 3 mice. Each circle in the graphs represents data from one mouse. Data are representative of three independent experiments. Mean and SD are indicated by horizontal lines in the data points. Source data are available for this figure: SourceData F8.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 18

Metadata

Authors
Andreani, V., Ramamoorthy, S., Fässler, R., & Grosschedl, R.
Affiliations
  • University of Freiburg (DE)
  • Max Planck Institute of Biochemistry (DE)
  • Max Planck Institute of Immunobiology and Epigenetics (DE)
Corresponding author
  • Andreani, Virginia
  • Grosschedl, Rudolf
Venue
Journal of Experimental Medicine
Published
2022-11-09
Volume
220
Issue
1
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W4308736347
Cited by
18
References
95
Citations by year
2026: 3 · 2025: 7 · 2024: 6 · 2023: 2
FWCI
2.69
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Max Planck Society
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords
beta1 integrin, marginal zone B cells, B cell differentiation, plasma cell differentiation, PI3K signaling, Ras/ERK pathway, B cell receptor signaling, integrin-linked kinase, Grb2, transitional B cells, innate-like B cells
MeSH terms
Animals, Cell Differentiation, Signal Transduction, Integrins, Integrin beta1, Phosphatidylinositol 3-Kinases, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.